AION Labs

A venture studio building AI companies to revolutionize drug discovery and development.

Incubator Rehovot, Israel Est. 2021
Last updated 2026-11-10
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$1.4M
total disclosed, rounds participated
Stages
Pre-Seed, Seed

About

AION Labs is an Israeli venture studio focused on the adoption of artificial intelligence (AI) and machine learning (ML) in pharmaceutical discovery and development processes. It was formed after winning a government tender in 2020 and officially launched in October 2021. AION Labs is a unique partnership backed by major companies in the pharmaceutical, technology, and investing sectors, including AstraZeneca, Merck KGaA, Pfizer, Teva Pharmaceuticals, Amazon Web Services (AWS), Israel Biotech Fund, Amiti Ventures, and BioMed X, with support from the Israel Innovation Authority. The venture studio aims to create and adopt groundbreaking AI technologies to transform drug discovery and development, ultimately improving health and patient outcomes globally. They work by identifying R&D challenges, assembling multidisciplinary teams of scientist-founders, and providing them with pre-seed funding, access to proprietary data, mentorship from pharma experts, and comprehensive company-building support. AION Labs has launched over ten companies in five years and achieved its first exit in 2026 with the acquisition of CombinAble.AI by insitro.

Portfolio · 1

Q&A

What is AION Labs' primary focus as an investor?
AION Labs operates as a venture studio dedicated to building AI companies that aim to revolutionize drug discovery and development processes.
When was AION Labs founded and what was its origin?
AION Labs was officially launched in October 2021, following its win of a government tender in 2020.
Which major companies back AION Labs?
AION Labs is backed by a partnership that includes AstraZeneca, Merck KGaA, Pfizer.
What is AION Labs' investment thesis?
AION Labs' thesis is to leverage emerging AI and computational technologies to accelerate the creation, validation, and scaling of solutions for drug discovery and development. They use a co-development venture studio model to address pharma-defined unmet needs.
What investment stages does AION Labs focus on?
AION Labs focuses on Pre-Seed and Seed stage investments.
What are the preferred sectors for AION Labs' investments?
AION Labs primarily invests in the Health Tech & Life Sciences sectors.
What is AION Labs' preferred geographical focus for investments?
AION Labs' preferred geography for investments is Israel.
Who is the CEO of AION Labs?
Mati Gill serves as the CEO of AION Labs.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteaionlabs.com/
LinkedInlinkedin.com/company/76221365
X / Twittertwitter.com/AionLabs

Identifiers & details

Legal nameAION Labs Innovation Labs Ltd.
Founded2021-10

Radar intelligence

GitHub

Top reposvectorizedb, genegist, Gene-Enrichment-Analysis, GeneRIF-Network, Pubmed-Networks

Web history (Wayback)

Domainaionlabs.com